Guy Macdonald - Net Worth and Insider Trading
Guy Macdonald Net Worth
The estimated net worth of Guy Macdonald is at least $16,150 dollars as of 2024-11-12. Guy Macdonald is the Director of SCYNEXIS Inc and owns about 12,000 shares of SCYNEXIS Inc (SCYX) stock worth over $15,600. Guy Macdonald is also the Director of Tetraphase Pharmaceuticals Inc and owns about 250 shares of Tetraphase Pharmaceuticals Inc (TTPH) stock worth over $550. Details can be seen in Guy Macdonald's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Guy Macdonald has not made any transactions after 2020-12-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Guy Macdonald
Guy Macdonald Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Guy Macdonald owns 2 companies in total, including Tetraphase Pharmaceuticals Inc (TTPH) , and SCYNEXIS Inc (SCYX) .
Click here to see the complete history of Guy Macdonald’s form 4 insider trades.
Insider Ownership Summary of Guy Macdonald
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TTPH | Tetraphase Pharmaceuticals Inc | 2020-07-28 | director |
| SCYX | SCYNEXIS Inc | 2023-06-15 | director |
Guy Macdonald Latest Holdings Summary
Guy Macdonald currently owns a total of 2 stocks. Among these stocks, Guy Macdonald owns 12,000 shares of SCYNEXIS Inc (SCYX) as of December 21, 2020, with a value of $15,600 and a weighting of 96.59%. Guy Macdonald also owns 250 shares of Tetraphase Pharmaceuticals Inc (TTPH) as of December 6, 2019, with a value of $550 and a weighting of 3.41%.
Latest Holdings of Guy Macdonald
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SCYX | SCYNEXIS Inc | 2020-12-21 | 12,000 | 1.30 | 15,600 |
| TTPH | Tetraphase Pharmaceuticals Inc | 2019-12-06 | 250 | 2.20 | 550 |
Holding Weightings of Guy Macdonald
Guy Macdonald Form 4 Trading Tracker
According to the SEC Form 4 filings, Guy Macdonald has made a total of 1 transactions in SCYNEXIS Inc (SCYX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in SCYNEXIS Inc is the acquisition of 8,000 shares on December 21, 2020, which cost Guy Macdonald around $50,000.
According to the SEC Form 4 filings, Guy Macdonald has made a total of 1 transactions in Tetraphase Pharmaceuticals Inc (TTPH) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Tetraphase Pharmaceuticals Inc is the sale of 7,605 shares on December 6, 2019, which brought Guy Macdonald around $17,263.
Insider Trading History of Guy Macdonald
- 1
Guy Macdonald Trading Performance
GuruFocus tracks the stock performance after each of Guy Macdonald's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Guy Macdonald is 56.57%. GuruFocus also compares Guy Macdonald's trading performance to market benchmark return within the same time period. The performance of stocks bought by Guy Macdonald within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Guy Macdonald's insider trading performs compared to the benchmark.
Performance of Guy Macdonald
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 11.05 | | | | | |
| Relative Return to S&P 500(%) | 5.53 | | | | | |
Guy Macdonald Ownership Network
Ownership Network List of Guy Macdonald
Ownership Network Relation of Guy Macdonald
Guy Macdonald Owned Company Details
What does Tetraphase Pharmaceuticals Inc do?
Who are the key executives at Tetraphase Pharmaceuticals Inc?
Guy Macdonald is the director of Tetraphase Pharmaceuticals Inc. Other key executives at Tetraphase Pharmaceuticals Inc include director & See Remarks Larry G. Edwards , director & 10 percent owner Steven Boyd , and director & 10 percent owner Armistice Capital Master Fund Ltd. .
Tetraphase Pharmaceuticals Inc (TTPH) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Tetraphase Pharmaceuticals Inc (TTPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Tetraphase Pharmaceuticals Inc (TTPH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Tetraphase Pharmaceuticals Inc (TTPH)'s detailed insider trading history can be found in Insider Trading Tracker table.
Tetraphase Pharmaceuticals Inc Insider Transactions
Guy Macdonald Mailing Address
Above is the net worth, insider trading, and ownership report for Guy Macdonald. You might contact Guy Macdonald via mailing address: C/o Idenix Pharmaceuticals, Inc., 60 Hampshire Street, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
